About Expert Systems, Inc

This startup develops an AI-enabled platform for preclinical drug discovery, covering target identification, virtual screening, and pharmacokinetics. Their platform combines human and artificial intelligence to accelerate the selection of drug candidates for clinical trials.

```xml <problem> The preclinical drug discovery process is often slow and inefficient, requiring significant time and resources to identify promising drug candidates. Traditional methods struggle to effectively integrate and analyze the vast amounts of data required for target identification, virtual screening, and pharmacokinetic analysis, leading to delays and increased costs. </problem> <solution> Expert Systems provides an AI-enabled platform designed to accelerate preclinical drug discovery by combining human expertise with artificial intelligence. The platform offers a suite of AI models covering target identification and selection, virtual screening, pharmacokinetics, off-target pharmacology, chemical liability assessment, and in vitro toxicology. By leveraging proprietary and public databases, along with advanced software, the platform facilitates informed decision-making and enables the selection of candidate drugs for clinical trials and research. The system also evaluates the intellectual property landscape and provides competitive intelligence to de-risk candidate selection. </solution> <features> - TTRENDS: A system for searching for prospective biotargets. - TargetGraph: A knowledge base and KGML models for target phenotype relationships. - DrugInteLLM: A suite of LLM-based tools to access biomedical data, databases, and ML models. - DiscoverNet: SMILES-based ML models for bioactivity and ADMET property prediction. - AI & Machine Learning Enabled: Platform supported by computer-aided drug design. </features> <target_audience> The primary audience includes pharmaceutical companies, biotechnology firms, and research institutions involved in early-stage drug discovery and development. </target_audience> ```

What does Expert Systems, Inc do?

Where is Expert Systems, Inc located?

Expert Systems, Inc is based in San Diego, United States.

Location

San Diego, United States

Employees

7 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Expert Systems, Inc

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

expertsystems.inc 100+

San Diego, United States

Funding

No funding information available.

Team (5+)

No team information available.

Company Description

Problem

The preclinical drug discovery process is often slow and inefficient, requiring significant time and resources to identify promising drug candidates. Traditional methods struggle to effectively integrate and analyze the vast amounts of data required for target identification, virtual screening, and pharmacokinetic analysis, leading to delays and increased costs.

Solution

Expert Systems provides an AI-enabled platform designed to accelerate preclinical drug discovery by combining human expertise with artificial intelligence. The platform offers a suite of AI models covering target identification and selection, virtual screening, pharmacokinetics, off-target pharmacology, chemical liability assessment, and in vitro toxicology. By leveraging proprietary and public databases, along with advanced software, the platform facilitates informed decision-making and enables the selection of candidate drugs for clinical trials and research. The system also evaluates the intellectual property landscape and provides competitive intelligence to de-risk candidate selection.

Features

TTRENDS: A system for searching for prospective biotargets.

TargetGraph: A knowledge base and KGML models for target phenotype relationships.

DrugInteLLM: A suite of LLM-based tools to access biomedical data, databases, and ML models.

DiscoverNet: SMILES-based ML models for bioactivity and ADMET property prediction.

AI & Machine Learning Enabled: Platform supported by computer-aided drug design.

Target Audience

The primary audience includes pharmaceutical companies, biotechnology firms, and research institutions involved in early-stage drug discovery and development.